Comparison of cellular uptake using 22 CPPs in 4 different cell lines

Bioconjugate Chemistry

Volumn 19, Issue 12, 2008, Pages 2363-2374

  Mueller, Judith ^a   Kretzschmar, Ines ^a   Volkmer, Rudolf ^a   Boisguerin, Prisca ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; PROTEINASE INHIBITOR; TRYPSIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN; CELL STRAIN COS7; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; NONHUMAN; PROTEIN TRANSPORT; SCREENING TEST; TEMPERATURE;

EID: 58149099412     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800194e     Document Type: Article

References (69)

1. Jarver, P., and Langel, U. (2006) Cell-penetrating peptides - a brief introduction. Biochim. Biophys. Acta 1758, 260-3.
2. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 62, 1839-49.
3. Lindsay, M. A. (2002) Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2, 587-94.
4. Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., and Chernomordik, L. V. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280, 15300-6.
5. Ferrari, M. E., Nguyen, C. M., Zelphati, O., Tsai, Y., and Felgner, P. L. (1998) Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum. Gene Ther. 9, 341-51.
6. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278, 34141-9.
7. Kaplan, I. M., Wadia, J. S., and Dowdy, S. F. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Controlled Release 102, 247-53.
8. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-5.
9. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-66.
10. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-50.
11. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-93.
12. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-88.
13. Lindgren, M., Hallbrink, M., Prochiantz, A., and Langel, U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
14. Zorko, M., and Langel, U. (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Delivery Rev. 57, 529-45.
15. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-7.
16. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998) Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-39.
17. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-40.
18. Pooga, M., Hallbrink, M., Zorko, M., and Langel, U. (1998) Cell penetration by transportan. Faseb J. 12, 67-77.
19. Poon, G. M., and Gariepy, J. (2007) Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem. Soc. Trans. 35, 788-93.
20. El-Andaloussi, S., Jarver, P., Johansson, H. J., and Langel, U. (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem. J. 407, 285-92.
21. Fotin-Mleczek, M., Welte, S., Mader, O., Duchardt, F., Fischer, R., Hufnagel, H., Scheurich, P., and Brock, R. (2005) Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. 118, 3339-51.
22. Maiolo, J. R., Ferrer, M., and Ottinger, E. A. (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712, 161-72.
23. Fischer, R., Mader, O., Jung, G., and Brock, R. (2003) Extending the applicability of carboxyfluorescein in solid-phase synthesis. Bioconjugate Chem. 14, 653-60.
24. Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv. Drug Delivery Rev. 60, 517-29.
25. Pujals, S., and Giralt, E. (2008) Proline-rich, amphipathic cell-penetrating peptides. Adv. Drug Delivery Rev. 60, 473-84.
26. Tunnemann, G., Ter-Avetisyan, G., Martin, R. M., Stockl, M., Herrmann, A., and Cardoso, M. C. (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14, 469-76.
27. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-90.
28. Elmquist, A., and Langel, U. (2003) In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 384, 387-93.
29. Palm, C., Jayamanne, M., Kjellander, M., and Hallbrink, M. (2007) Peptide degradation is a critical determinant for cell-penetrating peptide uptake. Biochim. Biophys. Acta 1768, 1769-76.
30. Trehin, R., Nielsen, H. M., Jahnke, H. G., Krauss, U., Beck-Sickinger, A. G., and Merkle, H. P. (2004) Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem. J. 382, 945-56.
31. Fischer, R., Kohler, K., Fotin-Mleczek, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-35.
32. Jones, A. T. (2007) Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell Mol. Med. 11, 670-84.
33. Patel, L. N., Zaro, J. L., and Shen, W. C. (2007) Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24, 1977-92.
34. Sahlin, S., Hed, J., and Rundquist, I. (1983) Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J. Immunol. Methods 60, 115-24.
35. Ma, Z., and Lim, L. Y. (2003) Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20, 1812-9.
36. Wan, C. P., Park, C. S., and Lau, B. H. (1993) A rapid and simple microfluorometric phagocytosis assay. J. Immunol. Methods 162, 1-7.
37. Zhang, L., Torgerson, T. R., Liu, X. Y., Timmons, S., Colosia, A. D., Hawiger, J., and Tam, J. P. (1998) Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc. Natl. Acad. Sci. U.S.A. 95, 9184-9.
38. Lanz, E., Slavik, J., and Kotyk, A. (1999) 2′,7′-Bis-(2- carboxyethyl)-5(6)-carboxyfluorescein as a dual-emission fluorescent indicator of intracellular pH suitable for argon laser confocal microscopy. Folia Microbiol. (Praha) 44, 429-34.
39. Matsuzaki, K., Yoneyama, S., Murase, O., and Miyajima, K. (1996) Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35, 8450-6.
40. Hallbrink, M., Oehlke, J., Papsdorf, G., and Bienert, M. (2004) Uptake of cell-penetrating peptides is dependent on peptide-tocell ratio rather than on peptide concentration. Biochim. Biophys. Acta 1667, 222-8.
41. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., and Merkle, H. P. (2007) Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm. Res. 24, 628-42.
42. Kosuge, M., Takeuchi, T., Nakase, I., Jones, A. T., and Futaki, S. (2008) Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjugate Chem. 19, 656-64.
43. Mano, M., Teodosio, C., Paiva, A., Simoes, S., and Pedroso de Lima, M. C. (2005) On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem. J. 390, 603-12.
44. Lindberg, M., Jarvet, J., Langel, U., and Graslund, A. (2001) Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochemistry 40, 3141-9.
45. Magzoub, M., Eriksson, L. E., and Graslund, A. (2003) Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles. Biophys. Chem. 103, 271-88.
46. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., and Beltram, F. (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8, 284-94.
47. Fretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G., and Jones, A. T. (2007) Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. Biochem. J. 403, 335-42.
48. Ziegler, A., Nervi, P., Durrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-48.
49. Oehlke, J., Lorenz, D., Wiesner, B., and Bienert, M. (2005) Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides. J. Mol. Recognit. 18, 50-9.
50. Abes, S., Williams, D., Prevot, P., Thierry, A., Gait, M. J., and Lebleu, B. (2006) Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. J. Controlled Release 110, 595-604.
51. El-Andaloussi, S., Johansson, H. J., Lundberg, P., and Langel, U. (2006) Induction of splice correction by cell-penetrating peptide nucleic acids. J. Gene Med. 8, 1262-73.
52. Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, S. V., and Perevozchikov, A. P. (2003) Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278, 42625-36.
53. Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R., and Ballmer-Hofer, K. (2003) Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278, 35109-14.
54. Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M., Newham, P., and Lindsay, M. A. (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145, 1093-102.
55. Potocky, T. B., Menon, A. K., and Gellman, S. H. (2003) Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278, 50188-94.
56. Abes, S., Moulton, H. M., Clair, P., Prevot, P., Youngblood, D. S., Wu, R. P., Iversen, P. L., and Lebleu, B. (2006) Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Controlled Release 116, 304-13.
57. Rousselle, C., Clair, P., Lefauconnier, J. M., Kaczorek, M., Scherrmann, J. M., and Temsamani, J. (2000) New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57, 679-86.
58. Saphire, A. C., Guan, T., Schirmer, E. C., Nemerow, G. R., and Gerace, L. (2000) Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem. 275, 4298-304.
59. Sadler, K., Eom, K. D., Yang, J. L., Dimitrova, Y., and Tam, J. P. (2002) Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 41, 14150-7.
60. Lin, Y. Z., Yao, S. Y., Veach, R. A., Torgerson, T. R., and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-8.
61. Lanford, R. E., Kanda, P., and Kennedy, R. C. (1986) Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 46, 575-82.
62. Ragin, A. D., Morgan, R. A., and Chmielewski, J. (2002) Cellular import mediated by nuclear localization signal peptide sequences. Chem. Biol. 9, 943-8.
63. Trehin, R., Krauss, U., Muff, R., Meinecke, M., Beck-Sickinger, A. G., and Merkle, H. P. (2004) Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm. Res. 21, 33-42.
64. Elmquist, A., Lindgren, M., Bartfai, T., and Langel, U. (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269, 237-44.
65. De Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., and Cailler, F. (2005) Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem. J. 390, 407-18.
66. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-6.
67. Morris, M. C., Vidal, P., Chaloin, L., Heitz, F., and Divita, G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25, 2730-6.
68. Fernandez-Carneado, J., Kogan, M. J., Castel, S., and Giralt, E. (2004) Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. Angew. Chem., Int. Ed. Engl. 43, 1811-4.
69. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-8.